Opposing a granted patent in the USA: post grant and
inter partes
review
Pharm Pat Anal
.
2019 May;8(3):61-63.
doi: 10.4155/ppa-2019-0006.
Authors
Paul A Ragusa
1
,
Zichao Zhang
1
Affiliation
1
Baker Botts LLP, Intellectual Property New York, New York, NY 10112, USA.
PMID:
31179901
DOI:
10.4155/ppa-2019-0006
No abstract available
Keywords:
review; patent invalidity; patent litigation; patent oppositions; post grant review.
Publication types
Editorial
MeSH terms
Drug Industry
Patents as Topic*
United States